Laman Utama539871 • BOM
Thyrocare Technologies Ltd
₹778.10
30 Jan, 4:01:27 PTG GMT+5:30 · INR · BOM · Penafian
SahamSekuriti tersenarai INIbu pejabat di IN
Tutup sebelumnya
₹783.90
Julat hari
₹771.80 - ₹784.05
Julat tahun
₹555.85 - ₹1,053.05
Permodalan pasaran
41.38B INR
Bilangan Purata
5.97K
Nisbah P/E
47.11
Hasil dividen
2.31%
Pertukaran utama
NSE
Berita pasaran
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
(INR)Dis 2024Perubahan T/T
Hasil
1.66B23.14%
Perbelanjaan pengendalian
610.00J17.67%
Pendapatan bersih
191.10J24.50%
Margin untung bersih
11.521.14%
Pendapatan bagi setiap syer
3.56
EBITDA
342.68J31.98%
Kadar cukai berkesan
32.13%
Jumlah aset
Jumlah liabiliti
(INR)Dis 2024Perubahan T/T
Pelaburan tunai dan jangka pendek
1.38B38.47%
Jumlah aset
Jumlah liabiliti
Jumlah ekuiti
4.89B
Syer tertunggak
52.99J
Harga kepada buku
8.58
Pulangan pada aset
Pulangan pada modal
12.16%
Perubahan bersih dalam tunai
(INR)Dis 2024Perubahan T/T
Pendapatan bersih
191.10J24.50%
Tunai daripada operasi
Tunai daripada pelaburan
Tunai daripada pembiayaan
Perubahan bersih dalam tunai
Aliran tunai bebas
Perihal
Thyrocare Technologies Limited is an Indian multinational chain of diagnostic and preventive care laboratories, headquartered in Navi Mumbai. As of 2021, the company has a total of 1,122 outlets and collection centers across India and parts of Nepal, Bangladesh and the Middle East. On 26 June 2021, Indian e-pharmacy and online healthcare aggregator PharmEasy's parent API Holdings acquired a 66.1% controlling stake in Thyrocare, making Thyrocare the first Indian listed company to be acquired by a startup. Wikipedia
Diasaskan
1996
Tapak web
Pekerja
1,693
Temui lagi
Cari
Kosongkan carian
Tutup carian
Apl Google
Menu utama